Optometrists in Alma, MI Accepting Medicare

10 Optometrists found. Showing 1 - 10

State Street Optics Optometrist Medicare: Not Enrolled in Medicare Practice Location: 322 N State St, Alma, MI 48801 Phone: 989-463-1139

Mr. Jacob Zainea, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1321 Pine Ave, Alma, MI 48801 Phone: 989-463-1139

Megan Louise Lark, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1321 Pine Ave, Alma, MI 48801 Phone: 989-463-1139

Great Lakes Eye Institute Optometrist Medicare: Medicare Enrolled Practice Location: 623 W Warwick Dr, Suite 1, Alma, MI 48801 Phone: 989-463-1126    Fax: 989-463-6013

Dr. Kyle Lark, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1321 Pine Ave, Alma, MI 48801 Phone: 989-463-1139    Fax: 989-466-2808

James Seals Peter Tacia Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1321 Pine Ave, Alma, MI 48801 Phone: 989-463-1139    Fax: 989-466-2808

Dr. Garrett W Whitmore, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1321 Pine Ave, Alma, MI 48801 Phone: 989-463-1139    Fax: 989-466-2808

Katie Marie Ratliffe, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 7700 N Alger Rd, Alma, MI 48801 Phone: 989-463-6770

Alma Optics Optometrist Medicare: Medicare Enrolled Practice Location: 1321 Pine Ave, Alma, MI 48801 Phone: 989-463-1139    Fax: 989-466-2808

Dr. James Harold Seals, OD Optometrist Medicare: Medicare Enrolled Practice Location: 1321 Pine Ave, Alma, MI 48801 Phone: 989-463-1139    Fax: 989-466-2808

News Archive

Study uncovers a promising drug candidate to minimize dyskinesia in Parkinson's patients

A new study from Texas Biomedical Research Institute (Texas Biomed) and collaborators has identified a promising drug candidate to minimize uncontrolled, erratic muscle movements, called dyskinesia, associated with Parkinson's disease.

Study supports wider testing for immune-based therapies to treat advanced non-small cell lung cancer

Two clinical trials led by Johns Hopkins Kimmel Cancer Center researchers in collaboration with other medical centers, testing experimental drugs aimed at restoring the immune system's ability to spot and attack cancer, have shown promising early results in patients with advanced non-small cell lung cancer, melanoma, and kidney cancer.

CMU receives $2.9 million DOD research grant to develop therapy for amputees

CMU's Jeffrey O. Hollinger, director of the center, and Professor Krzysztof Matyjaszewski have received a three-year, $2.9 million U.S. Department of Defense research grant to develop a therapy that would aid amputees, specifically wounded soldiers. The therapy aims to prevent bone nodules from forming in the muscle at the site of amputation, a painful condition that makes it difficult for amputees to wear limb prostheses.

£2.5 million to support further research into gene therapy for cystic fibrosis

The funding commitment was made in the Genetics White Paper, 'Our Inheritance, Our Future: Realising the potential of genetics in the NHS' and will help to ensure that those with cystic fibrosis benefit as soon as possible from the latest advances in genetic knowledge and technologies.

Read more Medical News

› Verified 3 days ago